Table 1.

Mean values of all other task variables (% premature response, choice latency, collect latency, omissions, trials completed) at each dose of RS 102221 delivered into either the lOFC or PrL

Region	Dose	% Premature responses	Choice latency	Collect latency	Omissions	Trials completed
lOFC	0	28.62 ± 4.05	1.28 ± 0.19	1.32 ± 0.07	1.50 ± 0.53	75.38 ± 5.28
	0.1	29.66 ± 3.65	1.20 ± 0.12	1.19 ± 0.04	0.94 ± 0.22	77.56 ± 5.11
	1.0	31.90 ± 4.71	1.22 ± 0.12	1.24 ± 0.03	0.39 ± 0.18	75.63 ± 5.05
	3.0	25.92 ± 3.72	1.30 ± 0.13	2.01 ± 0.42	0.94 ± 0.51	83.63 ± 6.41
PrL	0	34.05 ± 5.35	1.13 ± 0.12	1.42 ± 0.16	1.36 ± 0.72	69.98 ± 7.94
	0.1	31.94 ± 6.59	1.14 ± 0.12	1.29 ± 0.05	0.91 ± 0.44	73.37 ± 9.67
	1.0	28.64 ± 6.30	1.31 ± 0.17	1.21 ± 0.07	1.18 ± 0.46	75.41 ± 10.12
	3.0	24.19 ± 5.00	1.34 ± 0.15	1.24 ± 0.12	0.91 ± 0.44	78.66 ± 10.78

Data are mean ± SEM.